Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Fenofibrate

U.S. FDA Requirements: Fenofibrate

Pharmaceutical / Drug Definition : Inhibits triglyceride synthesis in liver, reducing levels of low- and very-low-density lipoproteins. Also increases uric acid secretion.

Registrar Corp assists Fenofibrate companies with:

  • FDA Registration Fenofibrate
  • FDA Listing Fenofibrate
  • FDA Label Requirements and Exceptions Fenofibrate
  • FDA Import Information Fenofibrate
  • FDA Detentions Fenofibrate (Fenofibrate Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Fenofibrate (Fenofibrate Suppliers)
       - Processors Fenofibrate
       - Repackers Fenofibrate
       - Relabelers Fenofibrate
       - Exporters Fenofibrate
       - Importers Fenofibrate
For more information about Fenofibrate, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco